Our Vision

PROSION, which stands for “PROLINE–VISION”, is a pharmaceutical drug discovery company. With our platform of breakthrough pharmaceutical building blocks, called ProMs, we explore new ways of drugging the undruggable.

ProMs work like “LEGO bricks” and can be combined into lead compounds targeting proteins linked with hard-to-treat diseases that currently cannot be addressed (or “drugged”) with existing pharmaceutical methods.

It is our mission to impact patients’ quality of life for the better.

Scientists analyzing protein molecule

Our Team

PROSION Team - Slim Chiha

Dr. Slim Chiha

Co-Founder and CEO

PROSION Team - Mutlu

Mutlu Yoenel

Co-Founder and CFO

PROSION Team

Dr. Wolfgang Söhngen

COO (ad interim)

PROSION Team - Matthias Muller

Dr. Matthias Müller

Head of Biochemistry

PROSION Team - Matthias Barone

Dr. Matthias Barone

Lead Scientist Biophysics

PROSION Team - Judith Bruns

Dr. Judith Bruns

Scientist Chemistry

Dominik Albat

Scientist Chemistry

PROSION Team - Mutlu

Mutlu Yoenel

Co-Founder and CFO

M.Sc. in Management from University College London (UCL)

| Full team to be on-boarded

Our Advisors

Prof. Dr. Hans Günther Profile

Prof. Dr. Hans-Günther Schmalz

Co-Founder and Strategic Advisor

Professor for Organic Chemistry at the University of Cologne

Dr. Ronald Kühne

Dr. Ronald Kühne

Co-Founder and Strategic Advisor

Head of Drug Discovery at the FMP in Berlin

PROSION Team - Peter Ten Dijke

Prof. Dr. Peter ten Dijke

Scientific Advisor and Academic Partner

Professor for Molecular Cell Biology at Leiden University

PROSION Team - Rainer Metternich

Prof. Dr. Rainer Metternich

Strategic Advisor

Senior Research Executive (Focus on Drug Discovery)

Academic Partners

Scroll to Top